Type 1 Diabetes
Regenerative Medicine Center of Orthopedics and Other Degenerative Diseases located in Glenview, IL
In the past, patients with Type 1 Diabetes traditionally had two treatment options: take regular doses of insulin, or control their blood sugar with diet and exercise. There may be an alternative method for managing the symptoms.. Please fill out a medical review form, or call our office in Glenview, Illinois.
Type 1 Diabetes Q & A
What is diabetes?
When you consume carbohydrates, they’re digested into glucose, which every cell in your body uses to produce energy. After glucose enters your bloodstream, insulin moves it out of your blood and into cells.
When you don’t have enough insulin, or your body can’t use the insulin that’s available, blood sugar increases beyond a healthy level. This results in a condition called diabetes.
What is Type 1 Diabetes?
Type 1 Diabetes is an autoimmune disease, in which your immune system attacks cells in the pancreas that produce insulin. This shortage of insulin causes blood glucose to rise to unhealthy levels.
Patient with Type 1 Diabetes develop symptoms such as:
- Increased thirst
- Frequent urination
- Extreme hunger
- Unintended weight loss
- Irritability and mood swings
- Fatigue and weakness
- Blurred vision
Although Type 1 Diabetes can occur at any age, it’s most often diagnosed during adolescence and early adulthood, with 85% of all cases appearing before the age of 20.
What are the long-term consequences of traditional treatments?
Type 1 Diabetes Mellitus – once known as “juvenile diabetes” or “insulin-dependent diabetes” – is a chronic condition in which the pancreas produces little or no insulin. This results in high blood sugar levels in the body. Patients with Type 1 Diabetes always need to use insulin to control their blood sugar. With children and adolescents, it is a very challenging condition to manage insulin, carbohydrate intake, and physical activities on a daily basis. Hypoglycemia is a common occurrence and requires immediate attention.
Long-term complications can occur at a relatively young age, and it is a disease which requires a great deal of emotional support. To understand the daily grind of counting carbohydrates, testing blood sugars multiple times each day, and dealing with the highs and lows (both physical and emotionally) can be very challenging for the patient and family.
Some long-term complications of Type 1 Diabetes that can develop over a span of 10 years are:
- Kidney Disease (Diabetic nephropathy including dialysis and kidney transplant)
- Nerve Disease (Diabetic neuropathy)
- Loss of Vision (Retinopathy)
- Heart Dysfunction (affects the large blood vessels, causing plaque to eventually build up and potentially leading to a heart attack)
- Peripheral Neuropathies (a sore that can get infected in the foot)
- Premature Demise
Who is GIOSTAR and What is Their Mission?
GIOSTAR (Global Institute of Stem Cell Therapy and Research) is home to the top experts in the field of stem cell research, and provides scientific know-how to GIOSTAR-CHICAGO. GIOSTAR-CHICAGO is an independently run facility from GIOSTAR. Involved in the field of stem cell research for almost two decades in the U.S.A, GIOSTAR has provided therapy to thousands of patients using their advanced protocols outside of the United States. GIOSTAR believes in the potential of supplementing traditional therapy with cellular rejuvenation therapy.
GIOSTAR opened the world’s first stem cell therapy hospital in India, and has plans to continue building stem cell therapy centers with health care partners around the world. Their goal is to develop therapy and offer hope to millions suffering around the globe with safe, effective and affordable healthcare.
What is the Possible Role of Stem Cells?
Within the body, there are different sources of stem cells – known as the “mother” or “master” cells capable of differentiating into virtually any type of cell. It has been documented by several scientific publications that stem cells may differentiate into a specific cell or tissue type.
A study by Dr. Tamir Rashid and a @KingsCollegeLon / @KCLstemcells team - published in @nature - examines the potential of "stem-cell like" HHyP cells for liver tissue regeneration, a possible alternative to transplants.
#LiverDisease #Research #StemCells
Promising breakthrough from OHSU in understanding bone disease: @rojasburke at @OHSUKnight reports on work by Dr Luiz Bertassoni and team that leverages stem cells to develop material that mimics human bone tissue.
#OHSUMedTech #Cancer #StemCells #Research